Breast implants linked to rare form of cancer

USA Reports 

People with breast implants have a small but increased risk for a rare form of deadly cancer.

The  federal Food and Drug Administration states breast implant-associated  anaplastic large cell lymphoma, a form of non-Hodgkin's lymphoma, has  been linked to at least nine deaths. On Tuesday, the agency confirmed  the disease can occur after breast implant surgery.

The  decision comes on the heels of a similar determination made by the World  Health Organization in 2016. WHO said the disease often presents itself  as fluid build-up near the implant. The FDA said it's more often  spotted in people undergoing 'implant revision operations" for seroma,  or fluid build-up. ALCL cases, the agency said, tend to occur more often  in textured implants than in people who receive smooth implants.

The  FDA has been digging into a possible link between implants and the  disease since 2011. It chose to update its understanding following the  WHO findings and after medical organizations published diagnosis and  treatment guidelines for ALCL.

Temporary 'vacation breasts' may be here by 2016

"The  FDA continues to believe that the available information suggests women  with breast implants have a very low, but increased risk of ALCL  compared to women who do not have breast implants," the agency said  Wednesday.

The  Lymphoma Research Foundation states ALCL accounts for about 1% of  non-Hodgkin's lymphoma cases. Most of the breast implant-related cases,  the FDA said, are treated by removing the implant. However, chemotherapy  and radiation also have been used.

The number of ALCL  cases related to breast implants is difficult to determine, the FDA  said, because of a lack of reporting data. However, the FDA did examine  359 medical reports, which found nine deaths. The Australian Therapeutic  Goods Administration analyzed 46 cases in Australia, where it found  three confirmed deaths.

The FDA recommends patients  educate themselves on the different options associated with breast  implants, particularly as it relates to texture.

"Before  getting breast implants," the agency said in a statement, "make sure to  talk to your health care provider about the benefits and risks of  textured-surface vs. smooth-surfaced implants."

Sponsored Content

Sponsored Content